APA (7th ed.) Citation

Kumar, D., & Humar, A. (2013). Editorial Commentary: Understanding Risk and Enhancing Safety in Immunotherapy Trials. Clinical Infectious Diseases, 56(2), 255. https://doi.org/10.1093/cid/cis855

Chicago Style (17th ed.) Citation

Kumar, Deepali, and Atul Humar. "Editorial Commentary: Understanding Risk and Enhancing Safety in Immunotherapy Trials." Clinical Infectious Diseases 56, no. 2 (2013): 255. https://doi.org/10.1093/cid/cis855.

MLA (9th ed.) Citation

Kumar, Deepali, and Atul Humar. "Editorial Commentary: Understanding Risk and Enhancing Safety in Immunotherapy Trials." Clinical Infectious Diseases, vol. 56, no. 2, 2013, p. 255, https://doi.org/10.1093/cid/cis855.